Our results showed that the TAPSE/PASP ratio, which is a non-invasive and easy-to-use index measured by echocardiography, determines the risk stratification of patients with SSc-PAH with reliable diagnostic accuracy, while a low TAPSE/PASP ratio predicts patients with poor prognosis. This evidence concerns the gene CPB1 and pulmonary arterial hypertension.